Physicians' Academy for Cardiovascular Education

PEGASUS: Clinical judgement needed

3' education - Mar. 16, 2015 - ACC 2015, San Diego - Valentin Fuster, MD Mount Sinai Hospital, New York,NY

Dr Valentin Fuster, MD (Mount Sinai Hospital, New York, NY) comments on the PEGASUS trial presented at ACC 2105 in San Diego and notes that the favourable results add to the trend for the use of dual antiplatelet agents in patients with chronic CAD. He empasises that clinical judgement is important due to the non-negligible incidence of bleeding.

News • 16-3-2015

Long term secondary prevention with ticagrelor reduces CV event rate

ACC 2015 PEGASUS trial shows that ticagrelor twice daily in addition to aspirin background therapy lowered the risk of CV death, myocardial infarction and stroke, until three years after MI.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: